REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Exergy21 Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Exergy21 Co., Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Exergy21 Co., Ltd. was founded in 1999, and is based in Seoul, South Korea. It works within the manufacturing and industrials and healthcare industries. The company has 11-50 employees.

Headquarters
99 Digital-Ro 9 Gil, Geumcheon-Gu
Seoul; Seoul; Postal Code: 153-777

Contact Details: Purchase the Exergy21 Co., Ltd. report to view the information.

Website: http://www.pharmswell.com

Basic Information
Total Employees:
Purchase the Exergy21 Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Exergy21 Co., Ltd. report to view the information.
Registered Capital:
Purchase the Exergy21 Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Exergy21 Co., Ltd. report to view the information.
Incorporation Date:
April 16, 1987
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
2.2%
Purchase this report to view the information.
1%
Subsidiaries
㈜팜스웰메디컬
48.5%
㈜팜스웨딩
40%
㈜유니콘벤처그룹
30%
Company Performance
Financial values in the chart are available after Exergy21 Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-23.69%▼
Total operating revenue
-31.96%▼
Operating Profit/Loss (EBIT)
-1.13%▼
EBITDA
23.07%▲
Net Profit/Loss for the Period
27.74%▲
Total Assets
-51.24%▼
Total Equity
-43.87%▼
Operating Profit Margin (ROS)
-32.78%▼
Net Profit Margin
7.38%▲
Return on Equity (ROE)
-8.62%▼
Debt/Equity
-7.85%▼
Quick Ratio
1.21%▲
Cash Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo